Recent issues surrounding the ADAPT-PO and SURE-2 trials place the spotlight on the difficulties developing oral carbapenem-based antibiotics and case their future into doubt.
Theodore S. Rader IV, MD, MS
Advertisement
Theodore S. Rader IV, MD, MS, is a second-year infectious disease fellow at the University of Pittsburgh Medical Center in Pennsylvania. His clinical interests include antimicrobial resistance, infection prevention, diagnostic stewardship, and transplant infectious diseases.
Articles by Theodore S. Rader IV, MD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
